Changes in splicing factor expression that regulate alternative splicing events have also been identified in lung cancer, affecting such proteins as QKI, RBM4, RBM5, RBM6, RBM10 and SRSF1, which are important splicing factors in lung cancer alternative splicing events 24. Here, RBM6 is linked to lung carcinoma.